55 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Lee JW, Kim JK, Kwon H, Lim W, Moon BI, Paik NS. Routine low-dose calcium supplementation after thyroidectomy does not reduce the rate of symptomatic hypocalcemia: a prospective randomized trial. Annals of Surgical Treatment and Research. 96: 177-184. PMID 30941321 DOI: 10.4174/astr.2019.96.4.177  0.32
2019 Mehdizadeh-Rad H, Singh J. Influence of Urbach energy, temperature, and longitudinal position in the active layer on carrier diffusion length in perovskite solar cells. Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry. PMID 30672099 DOI: 10.1002/cphc.201801038  0.92
2018 Yoon MK, Kim BY, Lee JY, Ha JH, Kim SA, Lee DH, Lee MS, Lee MK, Choi JS, Cho JH, Kim JH, Kim S, Song J, Park SG, Park BC, et al. Cytoplasmic pro-apoptotic function of the tumor suppressor p73 is mediated through a modified mode of recognition of the anti-apoptotic regulator Bcl-X. The Journal of Biological Chemistry. PMID 30429221 DOI: 10.1074/jbc.RA118.003061  0.32
2017 He E, Lew JB, Egger S, Banks E, Ward RL, Beral V, Canfell K. Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and Up Study cohort. Preventive Medicine. PMID 29109015 DOI: 10.1016/j.ypmed.2017.10.032  0.32
2015 Machiels JP, Haddad RI, Fayette J, Licitra LF, Tahara M, Vermorken JB, Clement PM, Gauler T, Cupissol D, Grau JJ, Guigay J, Caponigro F, de Castro G, de Souza Viana L, Keilholz U, ... ... Cohen EE, et al. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial. The Lancet. Oncology. 16: 583-94. PMID 25892145 DOI: 10.1016/S1470-2045(15)70124-5  0.32
2015 Taylor RJ, Saloura V, Jain A, Goloubeva O, Wong S, Kronsberg S, Nagilla M, Silpino L, de Souza J, Seiwert T, Vokes E, Villaflor V, Cohen EE. Ex vivo antibody-dependent cellular cytotoxicity inducibility predicts efficacy of cetuximab. Cancer Immunology Research. 3: 567-74. PMID 25769300 DOI: 10.1158/2326-6066.CIR-14-0188  0.32
2015 Raju SC, Hauff SJ, Lemieux AJ, Orosco RK, Gross AM, Nguyen LT, Savariar E, Moss W, Whitney M, Cohen EE, Lippman SM, Tsien RY, Ideker T, Advani SJ, Nguyen QT. Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma. Oral Oncology. 51: 470-5. PMID 25735654 DOI: 10.1016/j.oraloncology.2015.01.014  0.32
2015 Price KA, Cohen EE. Mechanisms of and therapeutic approaches for overcoming resistance to epidermal growth factor receptor (EGFR)-targeted therapy in squamous cell carcinoma of the head and neck (SCCHN). Oral Oncology. 51: 399-408. PMID 25725588 DOI: 10.1016/j.oraloncology.2015.01.018  0.32
2015 Cohen EE, Kocherginsky M, Karrison T, Seiwert TY, Haraf DJ, Brockstein B, Vokes EE. Reply to s. Chakraborty et al. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 968. PMID 25667282 DOI: 10.1200/JCO.2014.59.6189  0.32
2015 Schechter RB, Nagilla M, Joseph L, Reddy P, Khattri A, Watson S, Locati LD, Licitra L, Greco A, Pelosi G, Carcangiu ML, Lingen MW, Seiwert TY, Cohen EE. Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy. Cancer Letters. 359: 269-74. PMID 25641339 DOI: 10.1016/j.canlet.2015.01.024  0.32
2015 Young NR, Soneru C, Liu J, Grushko TA, Hardeman A, Olopade OI, Baum A, Solca F, Cohen EE. Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo. Targeted Oncology. PMID 25559287 DOI: 10.1007/s11523-014-0353-6  0.32
2015 Xu B, Boero IJ, Hwang L, Le QT, Moiseenko V, Sanghvi PR, Cohen EE, Mell LK, Murphy JD. Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer. Cancer. 121: 1303-11. PMID 25537836 DOI: 10.1002/cncr.29207  0.32
2015 Simpson DR, Mell LK, Cohen EE. Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck. Oral Oncology. 51: 291-8. PMID 25532816 DOI: 10.1016/j.oraloncology.2014.11.012  0.32
2015 Keck MK, Zuo Z, Khattri A, Stricker TP, Brown CD, Imanguli M, Rieke D, Endhardt K, Fang P, Brägelmann J, DeBoer R, El-Dinali M, Aktolga S, Lei Z, Tan P, ... ... Cohen EE, et al. Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 870-81. PMID 25492084 DOI: 10.1158/1078-0432.CCR-14-2481  0.32
2015 Das LC, Karrison TG, Witt ME, Muller C, Stenson K, Blair EA, Cohen EE, Seiwert TY, Haraf DJ, Vokes EE. Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 26: 198-205. PMID 25361984 DOI: 10.1093/annonc/mdu511  0.32
2015 Khattri A, Zuo Z, Brägelmann J, Keck MK, El Dinali M, Brown CD, Stricker T, Munagala A, Cohen EE, Lingen MW, White KP, Vokes EE, Seiwert TY. Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma. Oral Oncology. 51: 53-8. PMID 25255959 DOI: 10.1016/j.oraloncology.2014.08.014  0.32
2015 Gallop K, Kerr C, Simmons S, McIver B, Cohen EE. A qualitative evaluation of the validity of published health utilities and generic health utility measures for capturing health-related quality of life (HRQL) impact of differentiated thyroid cancer (DTC) at different treatment phases. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 24: 325-38. PMID 25106505 DOI: 10.1007/s11136-014-0776-7  0.32
2015 Cohen EH, Tong F. Neural mechanisms of object-based attention. Cerebral Cortex (New York, N.Y. : 1991). 25: 1080-92. PMID 24217991 DOI: 10.1093/cercor/bht303  1
2014 Tortorici MA, Cohen EE, Pithavala YK, Garrett M, Ruiz-Garcia A, Kim S, Fruehauf JP. Pharmacokinetics of single-agent axitinib across multiple solid tumor types. Cancer Chemotherapy and Pharmacology. 74: 1279-89. PMID 25336084 DOI: 10.1007/s00280-014-2606-6  0.32
2014 Gross AM, Orosco RK, Shen JP, Egloff AM, Carter H, Hofree M, Choueiri M, Coffey CS, Lippman SM, Hayes DN, Cohen EE, Grandis JR, Nguyen QT, Ideker T. Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss. Nature Genetics. 46: 939-43. PMID 25086664 DOI: 10.1038/ng.3051  0.32
2014 Cohen EE, Karrison TG, Kocherginsky M, Mueller J, Egan R, Huang CH, Brockstein BE, Agulnik MB, Mittal BB, Yunus F, Samant S, Raez LE, Mehra R, Kumar P, Ondrey F, et al. Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 2735-43. PMID 25049329 DOI: 10.1200/JCO.2013.54.6309  0.32
2014 Seiwert TY, Wang X, Heitmann J, Villegas-Bergazzi V, Sprott K, Finn S, O'Regan E, Farrow AD, Weichselbaum RR, Lingen MW, Cohen EE, Stenson K, Weaver DT, Vokes EE. DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer. Plos One. 9: e102112. PMID 25019640 DOI: 10.1371/journal.pone.0102112  0.32
2014 Machiels JP, Licitra LF, Haddad RI, Tahara M, Cohen EE. Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy. Bmc Cancer. 14: 473. PMID 24973959 DOI: 10.1186/1471-2407-14-473  0.32
2014 Seiwert TY, Fayette J, Cupissol D, Del Campo JM, Clement PM, Hitt R, Degardin M, Zhang W, Blackman A, Ehrnrooth E, Cohen EE. A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 25: 1813-20. PMID 24928832 DOI: 10.1093/annonc/mdu216  0.32
2014 Locati LD, Licitra L, Agate L, Ou SH, Boucher A, Jarzab B, Qin S, Kane MA, Wirth LJ, Chen C, Kim S, Ingrosso A, Pithavala YK, Bycott P, Cohen EE. Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessments. Cancer. 120: 2694-703. PMID 24844950 DOI: 10.1002/cncr.28766  0.32
2014 Kamaria M, Shea CR, Chin RK, Cohen EE, Maggiore R, Bolotin D. Eruptive cutaneous squamous cell carcinoma and psoriasis: response to cetuximab. Clinical and Experimental Dermatology. 39: 604-7. PMID 24758726 DOI: 10.1111/ced.12341  0.32
2014 Kuo WL, Sharifi MN, Lingen MW, Ahmed O, Liu J, Nagilla M, Macleod KF, Cohen EE. p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors. Plos One. 9: e90171. PMID 24599075 DOI: 10.1371/journal.pone.0090171  0.32
2013 Cohen E, Chen AY, Ferris RL, Lee A, Bernier J. Open Access in biomedical sciences: what the current turning point means more specifically to Oral Oncology contributors and readers. Oral Oncology. 49: 985-6. PMID 24045003 DOI: 10.1016/j.oraloncology.2013.09.002  0.32
2013 Elisei R, Schlumberger MJ, Müller SP, Schöffski P, Brose MS, Shah MH, Licitra L, Jarzab B, Medvedev V, Kreissl MC, Niederle B, Cohen EE, Wirth LJ, Ali H, Hessel C, et al. Cabozantinib in progressive medullary thyroid cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 3639-46. PMID 24002501 DOI: 10.1200/JCO.2012.48.4659  0.32
2013 Wong SJ, Campbell B, Massey B, Lynch DP, Cohen EE, Blair E, Selle R, Shklovskaya J, Jovanovic BD, Skripkauskas S, Dew A, Kulesza P, Parimi V, Bergan RC, Szabo E. A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia. Oral Oncology. 49: 970-6. PMID 23845699 DOI: 10.1016/j.oraloncology.2013.05.011  0.32
2013 Cohen E. Thyroid special issue. Oral Oncology. 49: 643. PMID 23773338 DOI: 10.1016/j.oraloncology.2013.05.008  0.32
2013 Cohen EH, Zaidi Q. Symmetry in context: salience of mirror symmetry in natural patterns. Journal of Vision. 13: 22. PMID 23729773 DOI: 10.1167/13.6.22  1
2013 Brägelmann J, Dagogo-Jack I, El Dinali M, Stricker T, Brown CD, Zuo Z, Khattri A, Keck M, McNerney ME, Longnecker R, Bieging K, Kocherginsky M, Alexander K, Salgia R, Lingen MW, ... ... Cohen EE, et al. Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA. Oral Oncology. 49: 525-33. PMID 23490885 DOI: 10.1016/j.oraloncology.2013.02.003  0.32
2013 Saloura V, Langerman A, Rudra S, Chin R, Cohen EE. Multidisciplinary care of the patient with head and neck cancer. Surgical Oncology Clinics of North America. 22: 179-215. PMID 23453331 DOI: 10.1016/j.soc.2012.12.001  0.32
2013 Kim DH, Vitol EA, Liu J, Balasubramanian S, Gosztola DJ, Cohen EE, Novosad V, Rozhkova EA. Stimuli-responsive magnetic nanomicelles as multifunctional heat and cargo delivery vehicles. Langmuir : the Acs Journal of Surfaces and Colloids. 29: 7425-32. PMID 23351096 DOI: 10.1021/la3044158  0.32
2013 Seiwert TY, Darga T, Haraf D, Blair EA, Stenson K, Cohen EE, Salama JK, Villaflor V, Witt ME, Lingen MW, Weichselbaum RR, Vokes EE. A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFeradeâ„¢ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 769-76. PMID 23104721 DOI: 10.1093/annonc/mds523  0.32
2013 Golden DW, Rudra S, Witt ME, Nwizu T, Cohen EE, Blair E, Stenson KM, Vokes EE, Haraf DJ. Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma. Oral Oncology. 49: 277-82. PMID 23102863 DOI: 10.1016/j.oraloncology.2012.10.003  0.32
2012 Nagilla M, Brown RL, Cohen EE. Cabozantinib for the treatment of advanced medullary thyroid cancer. Advances in Therapy. 29: 925-34. PMID 23104465 DOI: 10.1007/s12325-012-0060-6  0.32
2012 Cohen EE, Wu K, Hartford C, Kocherginsky M, Eaton KN, Zha Y, Nallari A, Maitland ML, Fox-Kay K, Moshier K, House L, Ramirez J, Undevia SD, Fleming GF, Gajewski TF, et al. Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4785-93. PMID 22872575 DOI: 10.1158/1078-0432.CCR-12-0110  0.32
2012 Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, Graham FJ, Hujoel PP, Kalmar JR, Koch WM, Lambert PM, Lingen MW, Oettmeier BW, Patton LL, Perkins D, et al. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. Texas Dental Journal. 129: 491-507. PMID 22779205  0.32
2010 Cohen EH, Jain A, Zaidi Q. The utility of shape attributes in deciphering movements of non-rigid objects. Journal of Vision. 10: 29. PMID 20884524 DOI: 10.1167/10.11.29  1
2008 Cohen EH, Singh M, Maloney LT. Perceptual segmentation and the perceived orientation of dot clusters: the role of robust statistics. Journal of Vision. 8: 6.1-13. PMID 19146239 DOI: 10.1167/8.7.6  1
2007 Cohen EH, Zaidi Q. The oblique effect and three-dimensional shape. Visual Cognition. 15: 80-83. PMID 21057595  1
2007 Cohen EH, Zaidi Q. Fundamental failures of shape constancy resulting from cortical anisotropy. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 12540-5. PMID 18003832 DOI: 10.1523/JNEUROSCI.4496-07.2007  1
2007 Cohen EH, Singh M. Geometric determinants of shape segmentation: tests using segment identification. Vision Research. 47: 2825-40. PMID 17868766 DOI: 10.1016/j.visres.2007.06.021  1
2007 Cohen EH, Schnitzer BS, Gersch TM, Singh M, Kowler E. The relationship between spatial pooling and attention in saccadic and perceptual tasks. Vision Research. 47: 1907-23. PMID 17499833 DOI: 10.1016/j.visres.2007.03.018  1
2007 Li X, Rayner K, Williams CC, Cave KR, Well AD. Eye movements and individual differences Visual Cognition. 15: 105-108. DOI: 10.1080/13506280600975486  1
2006 Cohen EH, Singh M. Perceived orientation of complex shape reflects graded part decomposition. Journal of Vision. 6: 805-21. PMID 16895460 DOI: 10.1167/6.8.4  1
2005 Cohen EH, Barenholtz E, Singh M, Feldman J. What change detection tells us about the visual representation of shape. Journal of Vision. 5: 313-21. PMID 15929654 DOI: 10:1167/5.4.3  1
2003 Barenholtz E, Cohen EH, Feldman J, Singh M. Detection of change in shape: an advantage for concavities. Cognition. 89: 1-9. PMID 12893121 DOI: 10.1016/S0010-0277(03)00068-4  1
2003 Barenholtz EB, Cohen E, Feldman J, Singh M. Non-accidental properties and change detection Journal of Vision. 3: 760a. DOI: 10.1167/3.9.760  1
2003 Feldman J, Singh M, Barenholtz EB, Cohen E. A psychophysical window onto the mental representation of shape Journal of Vision. 3: 664a. DOI: 10.1167/3.9.664  1
2003 Cohen EH, Barenholtz E, Singh M, Feldman J. Superior change detection at shape concavities Journal of Vision. 3: 270a. DOI: 10.1167/3.9.270  1
2002 Cohen EH, Pylyshyn ZW. Searching through subsets of moving items Journal of Vision. 2: 541a. DOI: 10.1167/2.7.541  1
2002 Leonard CJ, Pylyshyn ZW, Cohen EH, Dennis JL. The effect of a secondary monitoring task on Multiple Object Tracking Journal of Vision. 2: 240a. DOI: 10.1167/2.7.240  1
Show low-probability matches.